Device/Diagnostics Quarterly Deal Statistics, Q3 2015

15 Dec 2015

• By Maureen Riordan and Amanda Micklus

$1.4 billion in Q3 device financing was slightly lower than Q2's $1.8 billion with just one IPO versus Q2's seven. Acquisitions reached a high of $23 billion and diagnostics financing increased 30% over Q2 to $1 billion, while M&A activity at $1.2 billion showed a sharp decline from the previous quarter's $15.6 billion.

Device financing during 2015's third quarter reached $1.4 billion, a 22% dip from Q2's $1.8 billion total. (See Exhibit 1.) Late-stage venture capital rounds represented most of the Q3 fundraising, bringing in $511 million, or 36% of the total – a significant increase over Q2's $275 million in late-stage VC rounds (which made up just 15% of that quarter's aggregate financing).

Exhibit 1